Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES VIENNA (BOKU) holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action. This action is assigned to 1 distinct art unit, indicating a focused technical scope for the university's active patent applications. This suggests that the university's current commercialization efforts are centered on a specific biotechnological discovery.
The prosecution is handled by 1 distinct examiner, CHATTERJEE, JAYANTA. As the busiest examiner, CHATTERJEE, JAYANTA is responsible for 1 busiest examiner pending action. This single examiner manages the full extent of the university's current pending workload, centralizing the prosecution process for these assets. For the university, the outcome of this pending matter is dependent on the review of this examiner, making their specific examination history and preferences a critical factor in the current prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHATTERJEE, JAYANTA | 1 | 45.5% | +80.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18289937 | INTEGRATED MOLECULAR AND GLYCO-ENGINEERING OF COMPLEX VIRAL GLYCOPROTEINS | CHATTERJEE, JAYANTA | 46d overdue |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18289937 | INTEGRATED MOLECULAR AND GLYCO-ENGINEERING OF COMPLEX VIRAL GLYCOPROTEINS | CHATTERJEE, JAYANTA | 1662 | DP | Non-Final OA | 46d overdue | Pending | Nov 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial